| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Drugs Made In America Acquisition Corp. (DMAA) has 0 insiders with recent SEC Form 4 filings, including 4 buys and 2 sells. DMAA is classified in the Diversified Financial Services industry within the Financials sector.
| Role | Insider | Shares | Value | 30d |
|---|
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Feb 18, 2025 | Drugs Made In America Acquisition LLC | 10% Owner | Buy | 30,000 | $0.00 | - | +0.7% | |
| Feb 18, 2025 | Stockwell Lynn | CEO And Exe. Chair Of Board | Buy | 30,000 | $0.00 | - | +0.7% | |
| Jan 29, 2025 | Stockwell Lynn | CEO And Executive Cob | Sell | 5,698,363 | $0.00 | - | -57.8% | |
| Jan 29, 2025 | Drugs Made In America Acquisition LLC | 10% Owner | Sell | 5,698,363 | $0.00 | - | -57.8% | |
| Jan 29, 2025 | Stockwell Lynn | CEO And Executive Cob | Buy | 400,000 | $0.00 | - | -102.6% | |
| Jan 29, 2025 | Drugs Made In America Acquisition LLC | 10% Owner | Buy | 400,000 | $0.00 | - | +4.1% |